Literature DB >> 10872831

Molecular cloning and characterization of CRLM-2, a novel type I cytokine receptor preferentially expressed in hematopoietic cells.

T Hiroyama1, A Iwama, Y Morita, Y Nakamura, A Shibuya, H Nakauchi.   

Abstract

A murine expressed sequence tag (EST) showing homology with erythropoietin receptor (EPOR) was identified in the EST database. Cloning of the full-length cDNA revealed a 359 amino acid novel type I cytokine receptor, designated cytokine receptor like molecule-2 (CRLM-2). While CRLM-2 lacks typical WSXWS motif, it has a significant homology with EPOR, IL-2 receptor beta and gamma, and IL-9 receptor alpha. The murine CRLM-2 gene is composed of 8 exons, and an alternative mRNA splicing generates a variant transcript encoding a soluble CRLM-2. CRLM-2 is preferentially expressed in hematopoietic cells, particularly in hematopoietic progenitors and myeloid cells. Furthermore, CRLM-2 is constitutively associated with JAK2, a well-known tyrosine kinase that transmits signals from cytokine receptors. These data strongly suggest that CRLM-2 is a novel cytokine receptor involved in the regulation of hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872831     DOI: 10.1006/bbrc.2000.2764

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  TSLP and immune homeostasis.

Authors:  Shino Hanabuchi; Norihiko Watanabe; Yong-Jun Liu
Journal:  Allergol Int       Date:  2012-01-25       Impact factor: 5.836

2.  Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.

Authors:  Yrina Rochman; Mohit Kashyap; Gertraud W Robinson; Kazuhito Sakamoto; Julio Gomez-Rodriguez; Kay-Uwe Wagner; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Thymic stromal lymphopoietin induces tight junction protein claudin-7 via NF-kappaB in dendritic cells.

Authors:  Ryuta Kamekura; Takashi Kojima; Akira Takashima; Jun-ichi Koizumi; Noriko Ogasawara; Mitsuru Go; Ken-ichi Takano; Masaki Murata; Satoshi Tanaka; Shingo Ichimiya; Tetsuo Himi; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2010-03       Impact factor: 4.304

4.  Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

Authors:  Diederik van Bodegom; Jun Zhong; Nadja Kopp; Chaitali Dutta; Min-Sik Kim; Liat Bird; Oliver Weigert; Jeffrey Tyner; Akhilesh Pandey; Akinori Yoda; David M Weinstock
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

Review 5.  Thymic stromal lymphopoietin:a potential therapeutic target for allergy and asthma.

Authors:  David P Huston; Yong Jun Liu
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 6.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 7.  Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation.

Authors:  Vassili Soumelis; Yong-Jun Liu
Journal:  Springer Semin Immunopathol       Date:  2003-11-29

Review 8.  Thymic stromal lymphopoietin: master switch for allergic inflammation.

Authors:  Yong-Jun Liu
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307

9.  Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma.

Authors:  Katrin Sebastian; Andreas Borowski; Michael Kuepper; Karlheinz Friedrich
Journal:  Cell Commun Signal       Date:  2008-08-25       Impact factor: 5.712

10.  TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.

Authors:  Jun Zhong; Jyoti Sharma; Rajesh Raju; Shyam Mohan Palapetta; T S Keshava Prasad; Tai-Chung Huang; Akinori Yoda; Jeffrey W Tyner; Diederik van Bodegom; David M Weinstock; Steven F Ziegler; Akhilesh Pandey
Journal:  Database (Oxford)       Date:  2014-02-25       Impact factor: 3.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.